Diamonds and Dogs
1/31/13Celsion Corp. (CLSN)
Celsion is getting crushed today, down 81.17% at $1.51. The chemotherapy drug company saw its shares get demolished after negative news regarding its clinical trial. Celsion announced that its experimental liver cancer therapeutic, ThermoDox, failed to meet its phase 3 endpoint. ThermoDox is being tested for other types of cancer, however for liver cancer the treatment failed its final phase and will not receive US drug approval. CEO, Michael Tardugno said that the company would look for other ways to find strategic value for ThermoDox. Celsion dropped to a new 52-week low today.
Pitney Bowes Inc. (PBI)
Pitney Bowes is trying to climb back up to its highs today, up 20.53% at $14.44. The digital communication company saw its shares go in the green after releasing its earnings report. Pitney Bowes beat slightly on revenues and beat expectations on earnings per share. The company announced revenue of $1.29 billion beating analyst estimates of $1.27 billion. EPS came in at $0.56 again beating Wall Street estimates of $0.49 per share. Pitney Bowes is trading in the middle of its 52-week range of $10.34-$19.65.